News

Rheumatoid arthritis (RA) is an autoimmune disease that causes joint pain and inflammation. The condition is chronic, and there’s no cure. However, in recent years, new treatment options have ...
A new clinical test may be able to predict which biologic may be the most effective for each individual with rheumatoid ...
Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the ...
Myopenia, a condition marked by abnormal muscle loss, affects people across all age groups. Though linked to various diseases ...
DelveInsight's Rheumatoid Arthritis Pipeline report depicts a robust space with 75+ active players working to develop 80+ ...
Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.
Thorough screening for latent TB, hepatitis B, and hepatitis C before b/tsDMARD therapy in RA patients improves safety and ...
Patients with rheumatoid arthritis and cancer seek clear information on drug safety, cancer risks, and treatment decisions, a ...
Lupin and Zentiva announce a license and supply agreement for the commercialization of biosimilar Certolizumab Pegol across ...
Arthritis awareness emphasizes early detection of arthritis, a condition affecting joints, bones, and muscles. Recognizing symptoms like persistent jo ...